| Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure R Ferrari, T Bachetti, R Confortini, C Opasich, O Febo, A Corti, G Cassani, ... Circulation 92 (6), 1479-1486, 1995 | 792 | 1995 |
| Oxidative stress during myocardial ischaemia and heart failure. R Ferrari, L Agnoletti, L Comini, G Gaia, T Bachetti, A Cargnoni, C Ceconi, ... European heart journal 19, B2-11, 1998 | 397 | 1998 |
| Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-α L Agnoletti, S Curello, T Bachetti, F Malacarne, G Gaia, L Comini, ... Circulation 100 (19), 1983-1991, 1999 | 314 | 1999 |
| Chromogranin A in heart failure. A novel neurohumoral factor and a predictor for mortality C Ceconi, R Ferrari, T Bachetti, C Opasich, M Volterrani, B Colombo, ... European heart journal 23 (12), 967-974, 2002 | 274 | 2002 |
| Circulating levels of tumour necrosis factor-α and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis M Poloni, D Facchetti, R Mai, A Micheli, L Agnoletti, G Francolini, G Mora, ... Neuroscience letters 287 (3), 211-214, 2000 | 228 | 2000 |
| Endothelial cells in culture: a model for studying vascular functions T Bachetti, L Morbidelli Pharmacological research 42 (1), 9-19, 2000 | 200 | 2000 |
| Ischaemia–reperfusion injury activates matrix metalloproteinases in the human heart MM Lalu, E Pasini, CJ Schulze, M Ferrari-Vivaldi, G Ferrari-Vivaldi, ... European heart journal 26 (1), 27-35, 2004 | 195 | 2004 |
| Endothelial function and dysfunction in heart failure. R Ferrari, T Bachetti, L Agnoletti, L Comini, S Curello European heart journal 19, G41-7, 1998 | 174 | 1998 |
| Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE C Ceconi, G Francolini, A Olivares, L Comini, T Bachetti, R Ferrari European journal of pharmacology 577 (1-3), 1-6, 2007 | 163 | 2007 |
| Arginase pathway in human endothelial cells in pathophysiological conditions T Bachetti, L Comini, G Francolini, D Bastianon, B Valetti, M Cadei, ... Journal of molecular and cellular cardiology 37 (2), 515-523, 2004 | 158 | 2004 |
| Calmodulin kinase II inhibition prevents arrhythmias in RyR2 R4496C+/− mice with catecholaminergic polymorphic ventricular tachycardia N Liu, Y Ruan, M Denegri, T Bachetti, Y Li, B Colombi, C Napolitano, ... Journal of molecular and cellular cardiology 50 (1), 214-222, 2011 | 139 | 2011 |
| Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3 Y Ruan, M Denegri, N Liu, T Bachetti, M Seregni, S Morotti, S Severi, ... Circulation research 106 (8), 1374-1383, 2010 | 113 | 2010 |
| Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells T Bachetti, L Comini, S Curello, D Bastianon, M Palmieri, G Bresciani, ... Journal of molecular and cellular cardiology 37 (5), 939-945, 2004 | 107 | 2004 |
| Evidence for biological age acceleration and telomere shortening in COVID-19 survivors A Mongelli, V Barbi, M Gottardi Zamperla, S Atlante, L Forleo, M Nesta, ... International journal of molecular sciences 22 (11), 6151, 2021 | 102 | 2021 |
| Aorta and skeletal muscle NO synthase expression in experimental heart failure L Comini, T Bachetti, G Gaia, E Pasini, L Agnoletti, P Pepi, C Ceconi, ... Journal of molecular and cellular cardiology 28 (11), 2241-2248, 1996 | 102 | 1996 |
| Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? C Ceconi, S Curello, T Bachetti, A Corti, R Ferrari Progress in cardiovascular diseases 41 (1), 25-30, 1998 | 95 | 1998 |
| Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent L Comini, T Bachetti, A Cargnoni, D Bastianon, GL Gitti, C Ceconi, ... Pharmacological research 56 (1), 42-48, 2007 | 73 | 2007 |
| Mechanisms and clinical implications of endothelial dysfunction in arterial hypertension P Ambrosino, T Bachetti, SE D’Anna, B Galloway, A Bianco, V D’Agnano, ... Journal of cardiovascular development and disease 9 (5), 136, 2022 | 67 | 2022 |
| How do calcium antagonists differ in clinical practice? R Ferrari, F Cucchini, R Bolognesi, T Bachetti, A Boraso, P Bernocchi, ... Cardiovascular drugs and therapy 8 (3), 565-575, 1994 | 65 | 1994 |
| Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats T Bachetti, L Comini, E Pasini, A Cargnoni, S Curello, R Ferrari Journal of molecular and cellular cardiology 33 (3), 395-403, 2001 | 63 | 2001 |
Angelo CortiProfessor of Biochemistry, Vita-Salute San Raffaele University, Milan, Italy在 hsr.it 的电子邮件经过验证
